article thumbnail

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

To make precision medicine a reality, and reach everyone who can help or benefit, we need to design research studies much like consumer experiences – and offer clear value, beyond altruism, for taking part. And if participants have opted in to be made aware of their risks of genetic diseases, then communication has to be carefully considered.